Fiduciary Alliance’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.33M Sell
16,041
-645
-4% -$89.1K 0.18% 132
2026
Q2
$2.14M Buy
16,686
+98
+0.6% +$11.5K 0.15% 168
2026
Q1
$1.96M Buy
16,588
+804
+5% +$92.8K 0.12% 185
2025
Q4
$1.66M Sell
15,784
-408
-3% -$38.3K 0.11% 181
2025
Q3
$1.36M Sell
16,192
-1,345
-8% -$111K 0.09% 198
2025
Q2
$1.39M Sell
17,537
-48,271
-73% -$3.84M 0.1% 187
2025
Q1
$5.91M Sell
65,808
-7,022
-10% -$656K 0.58% 45
2024
Q4
$7.25M Buy
72,830
+3,629
+5% +$374K 0.73% 36
2024
Q3
$7.86M Sell
69,201
-5,074
-7% -$603K 1.04% 31
2024
Q2
$9.49M Buy
74,275
+3,181
+4% +$410K 1.54% 15
2024
Q1
$9.31M Sell
71,094
-990
-1% -$122K 1.64% 15
2023
Q4
$7.86M Buy
72,084
+6,104
+9% +$634K 1.55% 20
2023
Q3
$6.79M Buy
65,980
+2,648
+4% +$285K 1.57% 19
2023
Q2
$7.31M Buy
63,332
+16,727
+36% +$1.9M 1.57% 18
2023
Q1
$4.96M Buy
46,605
+3,168
+7% +$342K 1.24% 27
2022
Q4
$4.82M Buy
+43,437
New +$4.44M 1.25% 23

Other funds holding MRK

Fiduciary Alliance's MRK Position: Q3 2026 in Review

Fiduciary Alliance reduced its Merck (MRK) stake by 3.9% in Q3 2026, selling an estimated $89.1K and leaving 16,041 shares worth $2.33M. The position accounts for 0.18% of the portfolio, ranked #132.

Fiduciary Alliance first reported a position in MRK in Q4 2022 and has held it in 16 quarters since. The position peaked at $9.49M in Q2 2024. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Fiduciary Alliance held 16,041 shares of Merck worth $2.33M as of Q3 2026.
  • Fiduciary Alliance sold 645 Merck shares in Q3 2026, an estimated $89.1K.
  • Merck made up 0.18% of Fiduciary Alliance's portfolio in Q3 2026, its #132 holding.
  • Fiduciary Alliance first reported a position in Merck in Q4 2022 and has held it in 16 quarters since.
  • Fiduciary Alliance's Merck position peaked at $9.49M in Q2 2024.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Fiduciary Alliance's 13F filing for Q3 2026, filed 13 Oct 2026.